Jorge Reis-Filho

Jorge Reis-Filho serves as the Vice President of Cancer Biomarker Development at AstraZeneca, bringing extensive expertise to the role. Additionally, Jorge operates as a consultant for SAGA Diagnostics AB and Repare Therapeutics, and holds a position as a consultant and member of the Scientific Advisory Board at Paige. Furthermore, Jorge contributes to the field as a board member for Grupo Oncoclínicas.